Venus Cochlear News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BONEBRIDGE (MED-EL), Ponto 4 (Oticon Medical), Esteem® osseointegrated active middle ear implant (AMEI) (Envoy Medical), Venus Cochlear implant system (Nurotron Biotechnology) are some of the Age-related Hearing Loss devices available in the market. Most of these available devices are FDA-approved and are CE marked. Certain emerging devices/therapeutics in the Age-related Hearing Loss market comprise the Acclaim® Cochlear Implant FX-322 (Frequency Therapeutics), among others. On June 29, 2020, Acclaim® cochlear implant was granted the Breakthrough Device Designation from the FDA. In M...

Share: Hereditary Deafness Market Expected to Rise by a CAGR of 4.09% by 2026, Claims DelveInsight The Hereditary Deafness market is anticipated to surge due to an increasing prevalence of hearing loss patients and technological advancements.   DelveInsight's Hereditary Deafness Market and Competitive Insight Report provides the current and forecast market and comprises Hereditary Deafness market trends and key competitors. DelveInsight estimated the market to grow at a high CAGR over the study period of 2018 – 2026.   Key Highlights of : Deafness can be transferred from parents to th...